Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Awad

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Hematoma Evacuation and Risk of Subsequent Ischemic Stroke and Coronary Ischemic Events: MISTIE III and ATACH-2 AnalysisWendy C Ziai, William Harris, Adnan I Qureshi, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Current and Future Treatment Options for Cerebral Cavernous MalformationsLeslie Morrison, Juan Gutierrez, Cenk Ayata, et al.
CNS Drugs|July 8, 2025
Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled TrialStuart Madden, Issam Awad, Miguel A Lopez-Toledano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 26, 2024
Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trialPhilip Sun, Shervin Badihian, Radhika Avadhani, et al.
Neurocritical Care|February 14, 2014
Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhageDaniel B Herrick, Natalie Ullman, Saman Nekoovaght-Tak, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 9, 2022
β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformationsSara McCurdy, Jenny Lin, Robert Shenkar, et al.
Neurocritical Care|September 16, 2025
Impact of Minimally Invasive Surgery on Midline Shift and Outcomes in Large Supratentorial Spontaneous Intracerebral Hemorrhage: Post Hoc Analysis of MISTIE IIIWendy C Ziai, Anusha Yarava, Joshua B Gruber, et al.
Journal of the American Heart Association|March 12, 2024
Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-AnalysisBasel Musmar, Hamza Salim, Jihad Abdelgadir, et al.
Clinical Researcher (Alexandria, Va.)|September 18, 2018
African American Screening and Enrollment in (Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage III) CLEAR IIIKaren Lane, Maningbe Keita, Radhika Avadhani, et al.
Neurology|September 8, 2023
Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled TrialAbdulaziz T Bako, Thomas Potter, Alan P Pan, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Hematoma Evacuation and Risk of Subsequent Ischemic Stroke and Coronary Ischemic Events: MISTIE III and ATACH-2 AnalysisWendy C Ziai, William Harris, Adnan I Qureshi, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Current and Future Treatment Options for Cerebral Cavernous MalformationsLeslie Morrison, Juan Gutierrez, Cenk Ayata, et al.
CNS Drugs|July 8, 2025
Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled TrialStuart Madden, Issam Awad, Miguel A Lopez-Toledano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 26, 2024
Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trialPhilip Sun, Shervin Badihian, Radhika Avadhani, et al.
Neurocritical Care|February 14, 2014
Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhageDaniel B Herrick, Natalie Ullman, Saman Nekoovaght-Tak, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 9, 2022
β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformationsSara McCurdy, Jenny Lin, Robert Shenkar, et al.
Neurocritical Care|September 16, 2025
Impact of Minimally Invasive Surgery on Midline Shift and Outcomes in Large Supratentorial Spontaneous Intracerebral Hemorrhage: Post Hoc Analysis of MISTIE IIIWendy C Ziai, Anusha Yarava, Joshua B Gruber, et al.
Journal of the American Heart Association|March 12, 2024
Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-AnalysisBasel Musmar, Hamza Salim, Jihad Abdelgadir, et al.
Clinical Researcher (Alexandria, Va.)|September 18, 2018
African American Screening and Enrollment in (Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage III) CLEAR IIIKaren Lane, Maningbe Keita, Radhika Avadhani, et al.
Neurology|September 8, 2023
Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled TrialAbdulaziz T Bako, Thomas Potter, Alan P Pan, et al.
Pageof 5